Ocular Therapeutix Inc (NASDAQ: OCUL) stock enjoyed a major increase of 14.1% on 6/14/24. The shares closed at $5.75. Moreover, this advance was accompanied by unusually high trading volume at 184% of normal. The stock has risen 10.6% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, OCUL is expected to continue to be a modest Value Eraser.
Ocular Therapeutix has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Ocular Therapeutix has a very low Appreciation Score of 4 but a very high Power Rating of 92, producing the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment